Risk of Recurrence of Resected Stage I Non-small Cell Lung Cancer in Elderly Patients as Compared with Younger Patients

被引:57
|
作者
Goodgame, Boone [2 ]
Viswanathan, Avinash [2 ]
Zoole, Jennifer [3 ]
Gao, Feng [4 ]
Miller, C. Ryan [5 ,6 ]
Subramanian, Janakiraman [2 ]
Meyers, Bryan F. [3 ]
Patterson, Alexander G. [3 ]
Govindan, Ramaswamy [1 ,2 ]
机构
[1] Washington Univ, Sch Med, Div Med Oncol, St Louis, MO 63110 USA
[2] Alvin J Siteman Canc Ctr, Div Med Oncol, St Louis, MO USA
[3] Alvin J Siteman Canc Ctr, Div Cardiothorac Surg, St Louis, MO USA
[4] Alvin J Siteman Canc Ctr, Div Biostat, St Louis, MO USA
[5] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA
[6] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
关键词
Elderly; Lung cancer; Surgery; Stage I; Outcomes; LONG-TERM SURVIVAL; PULMONARY RESECTION; SURGICAL RESECTION; EPIDEMIOLOGY; SURVEILLANCE; MODEL;
D O I
10.1097/JTO.0b013e3181b6bc1b
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Half of all patients with non-small cell lung cancer (NSCLC) are 70 years or older at the time of diagnosis. Surgery is an option for fit elderly patients with early stage disease, but rates of disease recurrence after surgical resection arc not well described. We report the outcomes in elderly patients (170 years or older) with stage I NSCLC after surgical resection. Patients and Methods: We conducted a retrospective study of patients diagnosed with stage I NSCLC after surgical resection at Washington University School of Medicine-Alvin J. Siteman Cancer Center from 1990 to 2000. Demographic, pathologic, treatment, and follow-up data were collected. Recurrence rates and overall survival were calculated by the Kaplan-Meier method. Multivariate Cox proportional hazards models were used to detect associations between potential prognostic factors and survival and recurrence. Results: Of the 715 patients with stage I NSCLC, 286 were 70 years or older at diagnosis. In this elderly cohort, the median age was 74 years (range, 70-89 years) and 140 of them were women (49%). Lobectomy was performed in 237 patients (83%) whereas 43 patients (15%) had a wedge or segmental resection, and six patients (2%) underwent pneumonectomy. Clinical and pathologic characteristics were not statistically different between the elderly and younger cohorts, with the exception that older patients were more likely to be white (90% versus 80%, p = 0.0003) and less likely to be smokers (88% versus 95%, p = 0.019) compared with the Younger cohort. With a median follow-up of 4.6 years, the overall 5-year survival rate was 52% with a 5-year recurrence rate of 24%. in comparison, the patients younger than 70 years had a 5-year survival rate of 67% (p < 0.001) and a 5-year recurrence rate of 24%. Conclusions: Although overall survival was worse in elderly patients, estimated disease recurrence rates after resection were identical.
引用
收藏
页码:1370 / 1374
页数:5
相关论文
共 50 条
  • [41] Long-Term Outcome and Late Recurrence in Patients with Completely Resected Stage IA Non-small Cell Lung Cancer
    Maeda, Ryo
    Yoshida, Junji
    Ishii, Genichiro
    Aokage, Keiju
    Hishida, Tomoyuki
    Nishimura, Mitsuyo
    Nishiwaki, Yutaka
    Nagai, Kanji
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (08) : 1246 - 1250
  • [42] Early recurrence after surgical resection in patients with clinical stage I non-small cell lung cancer
    Kawachi, R
    Tsukada, H
    Takei, H
    Nogami, H
    Soma, T
    Koshi-Ishi, Y
    Goya, T
    LUNG CANCER, 2005, 49 : S40 - S40
  • [43] Development of a serum biomarker panel predicting recurrence in stage I non-small cell lung cancer patients
    Rinewalt, Daniel
    Shersher, David D.
    Daly, Shaun
    Fhied, Cristina
    Basu, Sanjib
    Mahon, Brett
    Hong, Edward
    Chmielewski, Gary
    Liptay, Michael J.
    Borgia, Jeffrey A.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2012, 144 (06): : 1344 - 1351
  • [44] Proteomic screening of completely resected tumors in relation to survival in patients with stage I non-small cell lung cancer
    Oshita, Fumihiro
    Morita, Atsushi
    Ito, Hiroyuki
    Kameda, Yoichi
    Tsuchiya, Eiju
    Asai, Shigeru
    Miyagi, Yohei
    ONCOLOGY REPORTS, 2010, 24 (03) : 637 - 645
  • [45] Early Recurrence after Surgical Resection in Patients with Pathological Stage I Non-small Cell Lung Cancer
    Kawachi, R.
    Tsukada, H.
    Nakazato, Y.
    Takei, H.
    Furuyashiki, G.
    Koshi-ishi, Y.
    Goya, T.
    THORACIC AND CARDIOVASCULAR SURGEON, 2009, 57 (08): : 472 - 475
  • [46] Serum carcinoembryonic antigen level in surgically resected clinical stage I patients with non-small cell lung cancer
    Sawabata, N
    Ohta, M
    Takeda, S
    Hirano, H
    Okumura, Y
    Asada, H
    Maeda, H
    ANNALS OF THORACIC SURGERY, 2002, 74 (01): : 174 - 179
  • [47] ASSESSING THE HEALTHCARE COST OF DIABETIC NON-SMALL CELL LUNG CANCER PATIENTS COMPARED TO NON-SMALL CELL LUNG CANCER PATIENTS
    Ruban, C.
    Blanchette, C. M.
    Howden, R.
    Kowalkowski, M.
    Marino, J.
    Saunders, W.
    VALUE IN HEALTH, 2017, 20 (09) : A428 - A428
  • [48] Hyperspectral Multiplex Immunohistochemistry and Recurrence in Resected Early Stage Non-small Cell Lung Cancer
    McGuire, A. L.
    Guillaud, M.
    Noureddine, K.
    Martin, S.
    English, J. C.
    Xiang, R.
    Arora, P.
    MacAulay, C.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S556 - S557
  • [49] A Nomogram for Predicting Recurrence in Stage I Non-Small Cell Lung Cancer
    Bian, Rongrong
    Zhao, Feng
    Peng, Bo
    Zhang, Jin
    Mao, Qixing
    Wang, Lin
    Chen, Qiang
    CLINICAL RESPIRATORY JOURNAL, 2024, 18 (11):
  • [50] Expression of dihydrodiol dehydrogenase in the resected stage I non-small cell lung cancer
    Chen, CY
    Hsu, CP
    Hsu, NY
    Shih, CS
    Lin, TY
    Chow, KC
    ONCOLOGY REPORTS, 2002, 9 (03) : 515 - 519